Selective Inhibition of Factor Xa Is More Efficient Than Factor VIIa–Tissue Factor Complex Blockade at Facilitating Coronary Thrombolysis in the Canine Model

This publication has 35 references indexed in Scilit:

• Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis
  Blood Coagulation & Fibrinolysis, 1996
• Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model
  Circulation, 1995
• Maintenance of canine coronary artery patency following thrombolysis with front loaded plus low dose maintenance conjunctive therapy. A comparison of factor Xa versus thrombin inhibition
  Cardiovascular Research, 1994
• The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.
  Journal of Clinical Investigation, 1993
• Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
  Circulation, 1992
• The coagulation cascade: initiation, maintenance, and regulation
  Biochemistry, 1991
• Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis
  Cardiovascular Research, 1991
• Regulation of coagulation by a multivalent Kunitz-type inhibitor
  Biochemistry, 1990
• Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis.
  Circulation, 1990
• Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for evaluation of anti-thrombotic agents
  Thrombosis Research, 1980